MDK and breast cancer: The best combination of biomarkers for the detection of BC in females included urine IL-12p70, IL-13, midkine and clusterin (AUROC 0.865, sensitivity 83.7%, specificity 80.1%, NPV 93.3% and PPV 60.3%) (Figure 1).